At Scan4Health Diagnostics, we use advanced molecular techniques to perform the BCR-ABL Gene Translocation (Qualitative) Test. This test detects the Philadelphia chromosome, an abnormal gene fusion associated with certain blood cancers. It is important for diagnosing and monitoring conditions like Chronic Myeloid Leukemia (CML) and some types of Acute Lymphoblastic Leukemia (ALL). Our molecular pathology team uses sensitive PCR-based methods to provide reliable detection, clear reporting, and fast results. We focus on accuracy, patient comfort, and clinical guidance, offering dependable testing support for people being evaluated for blood disorders.

Here is a rewritten preparation guide for the BCR-ABL Gene Translocation (Qualitative) Test at Scan4Health Diagnostics:

• Fasting is not necessary before the BCR-ABL test; you can eat and drink normally on the day of your appointment.
• Share details of any ongoing treatments—especially chemotherapy, targeted therapy, or immunosuppressants—with the Scan4Health team, as these medications can affect gene detection and interpretation.
• Bring all previous laboratory reports, bone marrow examinations, and notes from your oncologist to enable thorough and accurate clinical correlation.
• Stay well hydrated on the day of your test; drinking enough water helps make the blood collection smoother and more comfortable.
• If you’ve had a recent bone marrow test, let our staff know so that they can coordinate diagnostic timing and ensure consistency with your results.
• Keep your doctor’s prescription and a valid ID available for registration and necessary documentation.

Following these steps ensures accurate, hassle-free sample collection and the most reliable molecular diagnostics experience at Scan4Health Diagnostics.

The BCR-ABL Qualitative Test is a molecular diagnostic test used to detect a specific genetic abnormality: the fusion of the BCR gene on chromosome 22 and the ABL gene on chromosome 9. When a translocation rearranges these genes, they form the Philadelphia chromosome, which produces an abnormal fusion protein that causes uncontrolled growth of white blood cells.

This test is essential for diagnosing:

• Chronic Myeloid Leukemia (CML)
• Philadelphia chromosome–positive Acute Lymphoblastic Leukemia (Ph+ ALL)
• Rare cases of Acute Myeloid Leukemia (AML) with BCR-ABL positivity

The qualitative test determines whether the gene fusion is present or absent, providing a clear yes/no answer. It is performed using polymerase chain reaction (PCR), a highly sensitive technique capable of detecting even tiny amounts of abnormal genetic material.

Results help clinicians:

• Confirm or rule out suspected leukemia
• Decide on appropriate targeted therapies (e.g., tyrosine kinase inhibitors)
• Establish a baseline before starting treatment
• Understand the genetic behavior of the disease

At Scan4Health Diagnostics, molecular experts ensure that every sample undergoes strict quality checks and precise amplification procedures, giving you and your doctor confidence in the findings.